Endo International to Pay $8.05 Billion for Par Pharmaceutical – New York Times


New York Times
Endo International to Pay $8.05 Billion for Par Pharmaceutical
New York Times
The deal would create a specialty pharmaceutical company that would be one of the five largest generic drug makers based on sales in the United States, Endo said. Par Pharmaceutical shareholders would receive $6.5 billion in cash and 18 million Endo …
Endo Buys Par Pharma for $8.05 Billion Amid Hunt for DealsBloomberg
Endo to Buy Par Pharma for About $8 BillionWall Street Journal
Endo to Acquire Par Pharmaceutical, Strategically Expanding Generics Business PR Newswire (press release)
International Business Times -Irish Times
all 230 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd